Michèle Haumont

Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults

Étienne Sokal, Karel Hoppenbrouwers, Corinne Vandermeulen et al. · The Journal of Infectious Diseases · 2007 · 413 citations · Full text

Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adults

Michel Moutschen, Philippe Léonard, Étienne Sokal et al. · Vaccine · 2007 · 173 citations

Vaccination, Vaccine Safety, Vaccine Development +9

The surface antigen SAG3 mediates the attachment of Toxoplasma gondii to cell-surface proteoglycans

Alain Jacquet, Ludivine Coulon, Joël De Nève et al. · Molecular and Biochemical Parasitology · 2001 · 134 citations

Immunology, Antigen Processing, Autoimmunity +8

Protective Immunity against Congenital Toxoplasmosis with Recombinant SAG1 Protein in a Guinea Pig Model

Michèle Haumont, Louis Delhaye, Lida Garcia et al. · Infection and Immunity · 2000 · 72 citations · Full text

The varicella zoster virus glycoprotein B (gB) plays a role in virus binding to cell surface heparan sulfate proteoglycans

Alain Jacquet, Michèle Haumont, Daya Chellun et al. · Virus Research · 1998 · 55 citations

Virus Structure, Molecular Virology, Pathogenesis +5